Related Experiment Video
Updated: Jul 16, 2026

Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
Tectal gliomas with "low-grade appearance": Natural history on MR imaging
Danial Nasiri1, Lara Imwinkelried1, Philipp Becker2
1Department of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Background:
Tectal gliomas (TGs) are often indolent, but heterogeneous study populations in prior cohorts yielded ambiguous results concerning their natural history. We analyzed the natural history of TGs with low-grade appearance on MR imaging.
Methods:
We retrospectively analyzed TGs treated at our institution between 2010 and 2023. We included any space-occupying lesion of the tectum, excluding lesions with nodular contrast enhancement, cystic changes, or primarily pontine or mesencephalic involvement. Volumetric analysis was exclusively based on thin-sliced MRI sequences (≤2 mm). The primary outcome was tumor growth. The secondary outcome was relative annual growth rate (RGR).
Results:
Twenty patients met the inclusion criteria (median age 22.5 years, interquartile range [IQR] 18.7-39.6). Headache was the most common indication for imaging (60%). Twelve patients (60%) required cerebrospinal fluid (CSF) diversion for hydrocephalus at the time of diagnosis. These patients did not all present with headaches upon first consultation. Median follow-up was 6.3 years (IQR 2.2-9.8). Median volumetric change from baseline to last follow-up was +3.25% (IQR -10.53 to +28.47%), with a median RGR of 0.87%/year (IQR -1.28 to 11.05%/year). Only 1 patient exhibited tumor growth with a marginal increase in size over 12.8 years of follow-up. Based on MR imaging findings, no malignant transformation occurred in our cohort.
Conclusions:
TG with a low-grade imaging phenotype shows a predominantly stable long-term course. Management is typically limited to CSF diversion for hydrocephalus. Routine tumor-directed therapy is not supported in the absence of concerning clinical or imaging features. Magnetic resonance imaging surveillance remains essential to detect rare progression.

